Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Insulin Gel vs Liposomal Insulin for Joint Inflammation
NCT07790757Phase 1Completed
- Sponsor
- Deraya University
- Start
- Jul 2025
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Generex Oral-lyn in Shoulder inflammation and osteoarthritis (OA) (3 arms), sponsored by Deraya University. Primary endpoints: Pain scoring 0-10 at 8 weeks and Functional Status at 8 weeks. Started Jul 2025; status: completed.
02
Drugs
Generex Oral-lyn
03
Conditions
Shoulder inflammationosteoarthritis (OA)
Beyond the preview
Go deeper on NCT07790757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07790757.